208 related articles for article (PubMed ID: 12105882)
1. Helicobacter pylori eradication therapy in primary high-grade gastric MALT lymphoma.
Fischbach W
Gastroenterology; 2002 Jul; 123(1):393. PubMed ID: 12105882
[No Abstract] [Full Text] [Related]
2. Second complete remission of Helicobacter pylori negative gastric MALT lymphoma following antibiotic treatment.
Troch M; Püspök A; Streubel B; Chott A; Raderer M
Leuk Lymphoma; 2007 Jan; 48(1):204-6. PubMed ID: 17325871
[No Abstract] [Full Text] [Related]
3. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.
Miki H; Kobayashi S; Harada H; Yamanoi Y; Uraoka T; Sotozono M; Ohmori M
J Gastroenterol; 2001 Feb; 36(2):121-4. PubMed ID: 11227668
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies.
Isaacson PG; Diss TC; Wotherspoon AC; Barbazza R; De Boni M; Doglioni C
Gastroenterology; 1999 Sep; 117(3):750-1. PubMed ID: 10490369
[No Abstract] [Full Text] [Related]
5. Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages.
Cheung DY
Gut Liver; 2016 Sep; 10(5):659-60. PubMed ID: 27563015
[No Abstract] [Full Text] [Related]
6. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
Kim YS; Kim JS; Jung HC; Lee CH; Kim CW; Song IS; Kim CY
J Gastroenterol; 2002 Jan; 37(1):17-22. PubMed ID: 11824795
[TBL] [Abstract][Full Text] [Related]
7. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
Montalban C; Santon A; Boixeda D; Bellas C
Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658
[TBL] [Abstract][Full Text] [Related]
8. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial.
Thiede C; Wündisch T; Neubauer B; Alpen B; Morgner A; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A
Recent Results Cancer Res; 2000; 156():125-33. PubMed ID: 10802872
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
11. [Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori].
Delchier JC
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):453-8. PubMed ID: 12700502
[TBL] [Abstract][Full Text] [Related]
12. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
Ferreri AJ; Govi S; Ponzoni M
Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter and gastric MALT lymphoma.
Stolte M; Bayerdörffer E; Morgner A; Alpen B; Wündisch T; Thiede C; Neubauer A
Gut; 2002 May; 50 Suppl 3(Suppl 3):III19-24. PubMed ID: 11953328
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gastric marginal zone lymphoma of MALT type.
Stathis A; Bertoni F; Zucca E
Expert Opin Pharmacother; 2010 Sep; 11(13):2141-52. PubMed ID: 20586708
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
[TBL] [Abstract][Full Text] [Related]
16. [Use of vitaflor to eradicate Helicobacter pylori in treatment of MALT-lymphoma of the stomach].
Gershanovich ML; Petrov LN; Dobritsa VP; Kalinovskiĭ VP; Nikitina MV
Vopr Onkol; 2006; 52(6):696-8. PubMed ID: 17338252
[No Abstract] [Full Text] [Related]
17. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
18. Treatment for gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Maeda T; Niitsu N
Intern Med; 2006; 45(6):353-4. PubMed ID: 16617183
[No Abstract] [Full Text] [Related]
19. Helicobacter pylori associated gastric B cell MALT lymphoma: predictive factors for regression.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gut; 2001 Mar; 48(3):290-2. PubMed ID: 11171813
[No Abstract] [Full Text] [Related]
20. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
